BD BBL CHROMagar MRSA IIRecalls & reported problems across all models

We found 2 models of BD BBL CHROMagar MRSA II by Becton, Dickinson And Company in the FDA's device registry (GUDID). Together they are named in 124 adverse event reports in the FDA's MAUDE database, received between Nov 22, 2022 and Sep 9, 2025 — classified as 124 malfunctions.

The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (120 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Most reported BD BBL CHROMagar MRSA II problems

BD BBL CHROMagar MRSA II models

2 models, most reported first. Each model has its own page with its reports, recalls and device details.

• BD BBL™ CHROMagar® MRSA II 215229

  CULTURE MEDIA, ANTIMICROBIAL SUSCEPTIBILITY TEST, EXCLUDING MUELLER HINTON AGAR
  122 reports
• BD BBL™ CHROMagar® MRSA II 215228

  CULTURE MEDIA, ANTIMICROBIAL SUSCEPTIBILITY TEST, EXCLUDING MUELLER HINTON AGAR
  2 reports

Recent BD BBL CHROMagar MRSA II adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

• MalfunctionSep 9, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED WHILE USING ONE BD BBL¿ CHROMAGAR® MRSA II, THE PLATE DID NOT SHOW ANY GROWTH FOR PATIENT SAMPLES. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 23003289 ↗
• MalfunctionSep 9, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED WHILE USING ONE BD BBL¿ CHROMAGAR® MRSA II, THE PLATE DID NOT SHOW ANY GROWTH FOR PATIENT SAMPLES. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 23003281 ↗
• MalfunctionJul 10, 2025Defective Device

  ON [DATE REDACTED], THE ROUTINE WEEKLY METHICILLIN RESISTANT STAPH AUREUS (MRSA) SURVEILLANCE SCREENING WAS CONDUCTED IN THE NEONATAL INTENSIVE CARE UNIT (NICU). ADDITIONAL SURVEILLANCE SWABBING WAS ALSO CONDUCTED IN THE SPECIAL CARE NURSERIES (SCN). FOLLOWING THIS SCREENING/SWABBING IN THESE SPECIFIC UNITS, TEN (10) NEW CASES OF SUSPECTED NOSOCOMIAL MRSA INFECTIONS WERE IDENTIFIED IN THESE UNITS. THE VOLUME OF POSITIVE RESULTS WAS HIGHLY UNUSUAL AND RAISED AN ALERT FOR FURTHER INVESTIGATION AND ANALYSIS. A THOROUGH EPIDEMIOLOGICAL REVIEW WAS CONDUCTED AS WELL AS GENOME SEQUENCING OF THE ISOLATES. THE TEN (10) PATIENTS WERE RE-SWABBED AND TWO (2) RESULTED AS POSITIVE BUT EIGHT (8) RESULTED AS NEGATIVE FOR MRSA AND POSITIVE FOR MSSA [METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS]. GENOME SEQUENCING OF THE ORIGINAL ISOLATES IDENTIFIED PHENOTYPIC AST-7 MSSA CONFIRMING NO RELATEDNESS BETWEEN THE CASES. THE MRSA MEDIA WAS DETERMINED TO BE FAULTY. THIS INITIAL FINDING LED TO A MORE EXTENSIVE REVIEW LED BY THE INFECTIOUS DISEASE AND INFECTION CONTROL TEAMS OF THE USE OF THE MEDIA THROUGHOUT THE HOSPITAL. IT HAS BEEN DETERMINED THAT THIS EVENT SPANNED FROM [DATE REDACTED]-[DATE REDACTED],

  Patient problems: Drug Resistant Bacterial Infection

  MAUDE report 22467332 ↗
• MalfunctionJun 26, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  REPORT 4 OF 5: IT WAS REPORTED WHILE USING BD BBL¿ CHROMAGAR® MRSA II THAT ONE PATIENT SAMPLE APPEARED POSITIVE FOR METHICILLIN RESISTANT STAPHYLOCOCCAL AUREUS. AFTER THE QC FAILED, THE CUSTOMER PERFORMED ADDITIONAL TESTING TO CONFIRM THE PATIENT RESULT WAS METHICILLIN SUSCEPTIBLE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22340646 ↗
• MalfunctionJun 26, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  REPORT 1 OF 5: IT WAS REPORTED WHILE USING BD BBL¿ CHROMAGAR® MRSA II THAT ONE PATIENT SAMPLE APPEARED POSITIVE FOR METHICILLIN RESISTANT STAPHYLOCOCCAL AUREUS. AFTER THE QC FAILED, THE CUSTOMER PERFORMED ADDITIONAL TESTING TO CONFIRM THE PATIENT RESULT WAS METHICILLIN SUSCEPTIBLE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22340645 ↗
• MalfunctionJun 26, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  REPORT 29 OF 40. IT WAS REPORTED WHILE USING BD BBL¿ CHROMAGAR® MRSA II, THERE WERE PINK/PURPLE COLONIES FOR MRSA GROWTH. WHEN THE TESTING WAS REPEATED THE RESULTS WERE NEGATIVE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22340628 ↗
• MalfunctionJun 26, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  REPORT 3 OF 5: IT WAS REPORTED WHILE USING BD BBL¿ CHROMAGAR® MRSA II THAT ONE PATIENT SAMPLE APPEARED POSITIVE FOR METHICILLIN RESISTANT STAPHYLOCOCCAL AUREUS. AFTER THE QC FAILED, THE CUSTOMER PERFORMED ADDITIONAL TESTING TO CONFIRM THE PATIENT RESULT WAS METHICILLIN SUSCEPTIBLE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22338919 ↗
• MalfunctionJun 26, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  REPORT 2 OF 5: IT WAS REPORTED WHILE USING BD BBL¿ CHROMAGAR® MRSA II THAT ONE PATIENT SAMPLE APPEARED POSITIVE FOR METHICILLIN RESISTANT STAPHYLOCOCCAL AUREUS. AFTER THE QC FAILED, THE CUSTOMER PERFORMED ADDITIONAL TESTING TO CONFIRM THE PATIENT RESULT WAS METHICILLIN SUSCEPTIBLE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22338918 ↗
• MalfunctionJun 26, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  REPORT 5 OF 5: IT WAS REPORTED WHILE USING BD BBL¿ CHROMAGAR® MRSA II THAT ONE PATIENT SAMPLE APPEARED POSITIVE FOR METHICILLIN RESISTANT STAPHYLOCOCCAL AUREUS. AFTER THE QC FAILED, THE CUSTOMER PERFORMED ADDITIONAL TESTING TO CONFIRM THE PATIENT RESULT WAS METHICILLIN SUSCEPTIBLE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22338690 ↗
• MalfunctionJun 26, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  REPORT 24 OF 40. IT WAS REPORTED WHILE USING BD BBL¿ CHROMAGAR® MRSA II, THERE WERE PINK/PURPLE COLONIES FOR MRSA GROWTH. WHEN THE TESTING WAS REPEATED THE RESULTS WERE NEGATIVE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22338394 ↗
• MalfunctionJun 26, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  REPORT 36 OF 40 IT WAS REPORTED WHILE USING BD BBL¿ CHROMAGAR® MRSA II, THERE WERE PINK/PURPLE COLONIES FOR MRSA GROWTH. WHEN THE TESTING WAS REPEATED THE RESULTS WERE NEGATIVE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22338392 ↗
• MalfunctionJun 26, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  REPORT 28 OF 40. IT WAS REPORTED WHILE USING BD BBL¿ CHROMAGAR® MRSA II, THERE WERE PINK/PURPLE COLONIES FOR MRSA GROWTH. WHEN THE TESTING WAS REPEATED THE RESULTS WERE NEGATIVE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22338391 ↗
• MalfunctionJun 26, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  REPORT 31 OF 40. IT WAS REPORTED WHILE USING BD BBL¿ CHROMAGAR® MRSA II, THERE WERE PINK/PURPLE COLONIES FOR MRSA GROWTH. WHEN THE TESTING WAS REPEATED THE RESULTS WERE NEGATIVE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22338389 ↗
• MalfunctionJun 26, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  REPORT 34 OF 40. IT WAS REPORTED WHILE USING BD BBL¿ CHROMAGAR® MRSA II, THERE WERE PINK/PURPLE COLONIES FOR MRSA GROWTH. WHEN THE TESTING WAS REPEATED THE RESULTS WERE NEGATIVE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22338387 ↗
• MalfunctionJun 26, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  REPORT 40 OF 40. IT WAS REPORTED WHILE USING BD BBL¿ CHROMAGAR® MRSA II, THERE WERE PINK/PURPLE COLONIES FOR MRSA GROWTH. WHEN THE TESTING WAS REPEATED THE RESULTS WERE NEGATIVE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22338290 ↗

Other Becton, Dickinson And Company products

• BD Vacutainer SST10 models · 4,985 reports · 3 recalls
• BD Luer-Lok48 models · 5,117 reports
• BD Insyte Autoguard33 models · 4,465 reports · 8 recalls
• BD SafetyGlide17 models · 2,185 reports
• BD Vacutainer Eclipse Blood Collection Needle4 models · 1,880 reports
• BD Vacutainer Push Button Blood Collection Set9 models · 1,831 reports
• BD Nexiva25 models · 1,614 reports · 1 recall
• BD BACTEC MGIT Mycobacteria Growth Indicator Tubes2 models · 1,554 reports